{"Symbol": "FCSC", "AssetType": "Common Stock", "Name": "Fibrocell Science, Inc", "Description": "Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin and connective tissues in the United States. The company's gene therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, a gene therapy for localized scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions. It has collaboration agreement with Intrexon Corporation for the development of FCX-007, FCX-013, and products for the treatment of chronic inflammation and degenerative diseases of human joints. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was incorporated in 1992 and is based in Exton, Pennsylvania. As of December 13, 2019, Fibrocell Science, Inc. operates as a subsidiary of Castle Creek Pharmaceutical Holdings, Inc.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Other", "Industry": "Other", "Address": "405 Eagleview Boulevard, Exton, PA, United States, 19341", "FullTimeEmployees": "19", "FiscalYearEnd": "December", "LatestQuarter": "0000-00-00", "MarketCapitalization": "29177406", "EBITDA": "2463000", "PERatio": "10.53", "PEGRatio": "0", "BookValue": "1.101", "DividendPerShare": "None", "DividendYield": "0", "EPS": "0.283", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "0", "ReturnOnEquityTTM": "0", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "0", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "3", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "1.2751", "PriceToBookRatio": "2.7255", "EVToRevenue": "1.2147", "EVToEBITDA": "86.3177", "Beta": "None", "52WeekHigh": "None", "52WeekLow": "None", "50DayMovingAverage": "3", "200DayMovingAverage": "2.9776", "SharesOutstanding": "0", "SharesFloat": "0", "SharesShort": "0", "SharesShortPriorMonth": "0", "ShortRatio": "0", "ShortPercentOutstanding": "0", "ShortPercentFloat": "0", "PercentInsiders": "0", "PercentInstitutions": "0", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}